Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.231ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.231ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.231SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.231SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.231EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.231EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.231NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.231NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.49ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.49ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.49SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.49SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.49EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.49NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.49NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.67ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.67ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.67SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.67SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.67EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.67NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.190ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.190ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.190SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.190SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.190EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.190EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.190NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.190NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.120ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.120ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.120SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.120SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.120EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.120EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.120NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.120NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AM.3ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
AM.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
AM.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AM.3SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
AM.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AM.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AM.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used